Atlas Trials

Unresected Stage IIIb to IVM1c Melanoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Unresected Stage IIIb to IVM1c Melanoma

RecordFirmDate
Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma (NCT02366195)Amgen2015-04-07
Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma (NCT02297529)Amgen
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma (NCT02147951)Amgen

Track Unresected Stage IIIb to IVM1c Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.